Showing results (1211-1220 of 2,284) with videos related to

Sort By:
Pageof 229
HIV Medicine|March 30, 2010
HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapyT Puthanakit, G Jourdain, S Hongsiriwon, et al.
HIV Medicine|June 3, 2009
CYP2B6 G516T genotyping in a UK cohort of HIV-positive patients: polymorphism frequency and influence on efavirenz discontinuationVicki Powers, J Ward, M Gompels
HIV Medicine|June 4, 2009
Impact of prior pneumococcal vaccination on clinical outcomes in HIV-infected adult patients hospitalized with invasive pneumococcal diseaseA Imaz, V Falcó, M Peñaranda, et al.
HIV Medicine|June 6, 2009
The individual and combined influence of HIV and hepatitis C virus on dyslipidaemia in a high-risk Hispanic populationJ E Forrester, B H McGovern, M S Rhee, et al.
HIV Medicine|August 18, 2009
Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trialJade Ghosn, P Flandre, I Cohen-Codar, et al.
HIV Medicine|May 26, 2010
Assessment of factors influencing health-related quality of life in HIV-infected patientsL S Briongos Figuero, P Bachiller Luque, T Palacios Martín, et al.
HIV Medicine|April 23, 2010
HIV and pulmonary arterial hypertension: a systematic reviewS Janda, B S Quon, J Swiston
HIV Medicine|April 23, 2010
Effects of highly active antiretroviral therapy on vaccine-induced humoral immunity in HIV-infected adultsR González, P Castro, F García, et al.
HIV Medicine|April 23, 2010
Changing patterns in HIV-1 non-B clade prevalence and diversity in Italy over three decadesA Lai, C Riva, A Marconi, et al.
HIV Medicine|September 8, 2009
Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patientsPaola Cicconi, A Cozzi-Lepri, A Castagna, et al.
Pageof 229